These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9021705)

  • 1. Why do drugs work in CLL?
    Plunkett W; Begleiter A; Liliemark JO; Reed JC
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():1-11. PubMed ID: 9021705
    [No Abstract]   [Full Text] [Related]  

  • 2. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS; Hakimian D
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine in chronic leukaemia.
    Astrow AB
    Lancet; 1996 May; 347(9013):1420-1. PubMed ID: 8676619
    [No Abstract]   [Full Text] [Related]  

  • 4. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T; Kasznicki M
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
    Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
    Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine versus chlorambucil: is the debate over?
    Rai KR; Hollweg A
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
    Robertson LE; Keating MJ
    Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
    [No Abstract]   [Full Text] [Related]  

  • 10. Fludarabine phosphate--looking forward.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract]   [Full Text] [Related]  

  • 11. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
    McLaughlin P; Robertson LE; Keating MJ
    Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
    [No Abstract]   [Full Text] [Related]  

  • 13. More on purine analog-induced apoptosis in B cell chronic lymphocytic leukemia.
    Morabito F; Filangeri M; Sculli G; Oliva B
    Leukemia; 1998 Apr; 12(4):633-5. PubMed ID: 9557625
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia in the elderly population.
    Rai KR
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance to purine analogs in hairy cell leukemia.
    Kraut EH
    Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
    Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate.
    Coppo P; Scieux C; Ferchal F; Clauvel J; Lassoued K
    Ann Hematol; 2000 Jan; 79(1):43-5. PubMed ID: 10663621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When prognosis is poor, does false hope add to leukemia patients' pain?
    Miller M
    J Natl Cancer Inst; 1998 Aug; 90(16):1192-3. PubMed ID: 9719078
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Chlorodeoxyadenosine for multiple myeloma.
    Niesvizky R; Siegel D; Michaeli J
    Blood; 1993 Feb; 81(3):868-9. PubMed ID: 7679003
    [No Abstract]   [Full Text] [Related]  

  • 20. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.